Literature DB >> 26727670

[2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension].

Nazzareno Galiè1, Marc Humbert, Jean-Luc Vachiery, Simon Gibbs, Irene Lang, Adam Torbicki, Gérald Simonneau, Andrew Peacock, Anton Vonk Noordegraaf, Maurice Beghetti, Ardeschir Ghofrani, Miguel Angel Gomez Sanchez, Georg Hansmann, Walter Klepetko, Patrizio Lancellotti, Marco Matucci, Theresa McDonagh, Luc A Pierard, Pedro T Trindade, Maurizio Zompatori, Marius Hoeper.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26727670     DOI： 10.5603/KP.2015.0242

Source DB:  PubMed          Journal:  Kardiol Pol        ISSN： 0022-9032            Impact factor:   3.108


× No keyword cloud information.
  21 in total

Review 1.  Chronic thromboembolic pulmonary hypertension: a review.

Authors:  Cheryl Zhiya Chong; Edgar Lik Wui Tay; Ching Hui Sia; Kian Keong Poh
Journal:  Singapore Med J       Date:  2021-07       Impact factor: 1.858

2.  The Association of N-Terminal Pro-Brain Natriuretic Peptide With Time to Clinical Worsening in Hispanic Patients With Pulmonary Arterial Hypertension.

Authors:  Yacoub Khatab; Sayed Reshad Ghafouri; Haider Alkhateeb; Debabrata Mukherjee; Hernando Garcia; Nils Patrick Nickel
Journal:  Cardiol Res       Date:  2022-04-05

3.  Quantifying the direct public health care cost of systemic sclerosis: A comprehensive data linkage study.

Authors:  Kathleen Morrisroe; Wendy Stevens; Joanne Sahhar; Gene-Siew Ngian; Candice Rabusa; Nava Ferdowsi; Catherine Hill; Susanna Proudman; Mandana Nikpour
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.817

Review 4.  Kidney dysfunction in patients with pulmonary arterial hypertension.

Authors:  N P Nickel; J M O'Leary; E L Brittain; J P Fessel; R T Zamanian; J D West; E D Austin
Journal:  Pulm Circ       Date:  2017-03-13       Impact factor: 3.017

Review 5.  A review of therapeutic agents for the management of pulmonary arterial hypertension.

Authors:  Stella S Hahn; Mina Makaryus; Arunabh Talwar; Mangala Narasimhan; Gulrukh Zaidi
Journal:  Ther Adv Respir Dis       Date:  2016-09-19       Impact factor: 4.031

6.  Pirfenidone Inhibits Hypoxic Pulmonary Hypertension through the NADPH/ROS/p38 Pathway in Adventitial Fibroblasts in the Pulmonary Artery.

Authors:  Song Zhang; ZongXiu Yin; WeiDong Qin; XiaoLi Ma; Yao Zhang; EnXiu Liu; YanBiao Chu
Journal:  Mediators Inflamm       Date:  2020-06-11       Impact factor: 4.711

7.  Correlation between right ventricular-pulmonary artery coupling and the prognosis of patients with pulmonary arterial hypertension.

Authors:  Lin Nie; Jun Li; Sanping Zhang; Yaling Dong; Ming Xu; Menghuan Yan; Gangcheng Zhang; Laichun Song
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

8.  Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study.

Authors:  Kathleen Morrisroe; Molla Huq; Wendy Stevens; Candice Rabusa; Susanna M Proudman; Mandana Nikpour
Journal:  BMC Pulm Med       Date:  2016-09-27       Impact factor: 3.317

9.  Effectiveness and safety of exercise training and rehabilitation in pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Xiaomei Zeng; Haiming Chen; Honglian Ruan; Xiaojuan Ye; Jieying Li; Cheng Hong
Journal:  J Thorac Dis       Date:  2020-05       Impact factor: 3.005

10.  Prevalence of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease.

Authors:  Karolina Niklas; Arkadiusz Niklas; Tatiana Mularek-Kubzdela; Mariusz Puszczewicz
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.